Fifth Third Bancorp
NKTR icon

Fifth Third Bancorp’s Nektar Therapeutics NKTR Stock Holding History

Fifth Third Bancorp’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-210
Closed -$7.11K – 2812
2022
Q4 		$7.11K Buy
210
+41
+24% +$1.98K ﹤0.01% 2083
2022
Q3 		$8K Buy
169
+28
+20% +$1.67K ﹤0.01% 2028
2022
Q2 		$8K Buy
+141
New +$8.9K ﹤0.01% 2080
2021
Q4 		– Sell
-17
Closed -$5K – 2753
2021
Q3 		$5K Buy
+17
New +$4.09K ﹤0.01% 2206
2020
Q2 		– Sell
-4
Closed -$1K – 2188
2020
Q1 		$1K Sell
4
-7
-64% -$2.17K ﹤0.01% 2054
2019
Q4 		$3K Sell
11
-31
-74% -$8.99K ﹤0.01% 2018
2019
Q3 		$12K Sell
42
-27
-39% -$9.9K ﹤0.01% 1760
2019
Q2 		$37K Buy
69
+63
+1,050% +$31.6K ﹤0.01% 1457
2019
Q1 		$3K Sell
6
-12
-67% -$7.11K ﹤0.01% 2012
2018
Q4 		$9K Buy
18
+12
+200% +$7.24K ﹤0.01% 1807
2018
Q3 		$5K Buy
6
+3
+100% +$2.56K ﹤0.01% 1992
2018
Q2 		$2K Sell
3
-1
-25% -$1.15K ﹤0.01% 2184
2018
Q1 		$6K Buy
+4
New +$5.15K ﹤0.01% 2024
2016
Q1 		– Sell
-25
Closed -$6K – 2562
2015
Q4 		$6K Buy
25
+1
+4% +$206 ﹤0.01% 2137
2015
Q3 		$4K Buy
24
+9
+60% +$1.59K ﹤0.01% 2378
2015
Q2 		$3K Buy
+15
New +$2.58K ﹤0.01% 2458

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Fifth Third Bancorp's NKTR Position: Q1 2023 in Review

Fifth Third Bancorp sold out of Nektar Therapeutics (NKTR) in Q1 2023, closing a stake of 210 shares — an estimated $7.11K sold.

Fifth Third Bancorp first reported a position in NKTR in Q2 2015 and held it in 16 quarters. The position peaked at $37K in Q2 2019. 194 funds tracked by Wall St. Rank hold NKTR as of Q1 2023.

  • Fifth Third Bancorp reported no remaining Nektar Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Fifth Third Bancorp sold 210 Nektar Therapeutics shares in Q1 2023, an estimated $7.11K.
  • Fifth Third Bancorp first reported a position in Nektar Therapeutics in Q2 2015 and held it in 16 quarters.
  • Fifth Third Bancorp's Nektar Therapeutics position peaked at $37K in Q2 2019.
  • 194 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q1 2023.

Based on Fifth Third Bancorp's 13F filing for Q1 2023, filed 24 Apr 2023.